Skip to Content

Buprenorphine Hydrochloride Injection

Last Updated: December 14, 2020
Status: Resolved

Products Affected - Description
    • Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 1 count, NDC 12496-0757-01 - discontinued
Reason for the Shortage
    • Pfizer had buprenorphine injection on shortage due to manufacturing delays.
    • Par had buprenorphine injection on shortage due to increased demand.
Available Products
    • Buprenex injection, Indivior, 0.3 mg/mL, 1 mL ampule, 5 count, NDC 12496-0757-05
    • Buprenorphine injection, Par Pharmaceuticals, 0.3 mg/mL, 1 mL vial, 5 count, NDC 42023-0179-05
    • Buprenorphine injection, Pfizer, 0.3 mg/mL, 1 mL Carpuject syringe, 10 count, NDC 00409-2012-32

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated December 14, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 27, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.